| Deliverables |
Contents
|
Lead organisation
|
| D2.2 | Cost-effectiveness models for three case studies |
SYREON
|
| D2.3 | Budget impact models for three case studies |
SYREON
|
| D2.4 | Report with recommendation on the refinement of the guidance developed D1.1 |
SYREON
|
| D2.5 | Developed Models populated with input data from three EU Member States |
SYREON
|
| D3.1 | Report on a set of appropriate financing and payment models for personalised medicine for different types of health care systems in EU |
UOXF
|
| D3.2 | Report with action plan for the adoption of appropriate financing and payment models for personalised medicine across the EU |
UOXF
|
| D4.2 | Report on “The Benefits & Challenges of Personalised Medicine for the European Social Models of Health Care” with scenarios for personalised medicine futures, enhancing personalised medicine networks for health benefits, institutional support for personalised medicine and the significance of personalised medicine for the citizen |
AIT
|
| D5.2 | Technical report on the workshop on financing and payment models in the context of personalised medicine |
DLR
|
| D5.3 | Technical report on the outcomes of the Stakeholder Conference on “How can health/pharmaco-economic models along with financing and payment models support the sustainable implementation of personalised medicine in our health systems?” |
DLR
|
